İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2011 · article

Transthoracic Echocardiography Guidance during Percutaneous Closure of Patent Foramen Ovale

ISSN0742-2822
YÖKSİS OpenAlex Açık erişim · green
Yıl2011
Atıf15OpenAlex
Atıf17Semantic Scholar · 1 etkili
Yüzdelik%72,1
FWCI0,681,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q3

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıEchocardiography
  • Katalog eşleşmesi (ISSN)Echocardiography
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

BACKGROUND: Percutaneous closure of patent foramen ovale (PFO) has been increasingly performed for several indications; mostly due to cryptogenic stroke. In this study we aimed to evaluate the safety and efficacy of transthoracic echocardiographic (TTE) guidance during percutaneous closure of PFO in using the Amplatzer and Occlutech Figulla PFO occluder devices. METHODS: Between October 2005 and March 2011, 139 patients (74 male, mean age: 40.4 ± 10.3) underwent transcatheter PFO closure. In all patients transesophageal echocardiography performed subsequently to diagnose, assess the size and evaluate for suitability of the defect for percutaneous closure. During the procedure fluoroscopy and TTE were used for guidance. RESULTS: Among 139 patients, Amplatzer PFO occluder was used in 74 patients and in 65 of them Occlutech Figulla device was selected for occlusion. The indications for PFO closure were ischemic stroke in 98 (70.5%), recurrent transient ischemic attacks (TIA) in 40 (28.7%), peripheral embolism in 1 (0.8%) of the patients. In all patients, percutaneous intervention was performed successfully under TTE guidance. There have been no neurologic (recurrent strokes or TIAs) and cardiovascular complications during the immediate and long-term follow-up period (2-67 months, median 29). There was significant difference between the mean fluoroscopic time from the beginning which is 8.6 ± 3.4 min in the former versus 3.4 ± 1.9 min in the latter (P < 0.05). CONCLUSION: Our study confirms the efficacy and safety of TTE guidance during percutaneous closure of PFO, which shortens the procedural time and obviates the need for general anesthesia or endotracheal intubation.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

15atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 8 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2013 Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta-analysis of 28,142 patients from 203 studiesAtıf 159 · OpenAlex
  2. 2013 Short and long term complications of device closure of atrial septal defect and patent foramen ovale: Meta-analysis of 28,142 patients from 203 studiesAtıf 159 · OpenAlex
  3. 2013 Short and long term complications of device closure of atrial septal defect and patent foramen ovale Meta analysis of 28 142 patients from 203 studiesAtıf 159 · OpenAlex
  4. 2013 Transcatheter Interatrial Septal Defect Closure in a Large Cohort Midterm Follow up ResultsAtıf 32 · OpenAlex
  5. 2013 Transcatheter Interatrial Septal Defect Closure in a Large Cohort Midterm Follow up ResultsAtıf 32 · OpenAlex
  6. 2013 Transcatheter Interatrial Septal Defect Closure in a Large Cohort Midterm Follow up ResultsAtıf 32 · OpenAlex
  7. 2013 Transcatheter Interatrial Septal Defect Closure in a Large Cohort Midterm Follow up ResultsAtıf 32 · OpenAlex
  8. 2013 Transcatheter Interatrial Septal Defect Closure in a Large Cohort Midterm Follow up ResultsAtıf 32 · OpenAlex

Yazarlar

8
  1. Ali Oto 1
  2. KUDRET AYTEMİR 2
  3. SÜHEYLA ÖZKUTLU 3
  4. ERGÜN BARIŞ KAYA HACETTEPE ÜNİVERSİTESİ 4
  5. HİKMET YORGUN 5
  6. UĞUR CANPOLAT 6
  7. Ahmet Hakan Ateş 7
  8. Hilmi Özkutlu 8